Kumar Budur - May 1, 2023 Form 3 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Stock symbol
HRMY
Transactions as of
May 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/26/2024, 04:58 PM
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HRMY Common Stock 1.01K May 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HRMY Stock Options May 1, 2023 Common Stock 75K $49.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests with respect to 50% of the underlying shares on March 21, 2024, with the remaining shares vesting in twenty-four equal monthly installments beginning on April 21, 2024, subject to the Reporting Person's continued service through each applicable vesting date.